Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
Date:11/1/2007

/p>

restructuring were the decisions to discontinue further development of

ANA380, a nucleotide analog for the treatment of hepatitis B virus

(HBV) infection, halt all work on early discovery projects, and effect

an immediate reduction in force of approximately one-third of the

Company's employees, with several additional positions to be eliminated

in early 2008.

Recent Scientific Presentations

-- Reported ANA773 Dose Schedule Data. On October 25, 2007, Anadys

presented preclinical data on ANA773 during a poster session at the

2007 AACR-NCI-EORTC International Conference on Molecular Targets and

Cancer Therapeutics. The report showed the impact that varying the

dosing schedule has on the pharmacodynamic response to ANA773, a

prodrug of a toll-like receptor 7 agonist. Specifically, the report

described that immunostimulatory responses to ANA773 in vivo can be

modulated by schedule of administration.

-- Reported ANA598 Preclinical Data. On September 11, 2007, Anadys

presented preclinical data on ANA598, a non-nucleoside inhibitor of the

HCV NS5B polymerase, during a poster session at the 14th International

Symposium on Hepatitis C Virus and Related Viruses. The report

characterized the favorable antiviral, metabolic, pharmacokinetic and

preliminary toxicologic properties that supported the decision

announced in June to progress ANA598 to IND enabling studies and

subsequent clinical evaluation expected to commence in the second

quarter of 2008.

Webcast of Conference Call

Anadys will host a conference call today at 5:00 p.m. Eastern Daylight Time to discuss its third quarter financial results and operational highlights and to give an update on its programs. A live webcast of the call will be available online at '/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Global biostimulants market is expected to reach $2,524.02 ... of 12.5%. In order to cater to the ... impacts, farmers are looking to adopt natural compounds ... effectively & efficiently. Biostimulants are consequently seen as ... investments. , Leading companies in the biostimulants market ...
(Date:11/26/2014)... 2014 SoundConnect , an award ... to announce that Darren Suders has joined the team ... will drive the partner program through innovative ... , Darren brings more than 10-years of channel ... in channel operations, from policy development, to partner education ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 2014 ... is an in-depth research report on the Global ... report introduces Palmitic Acid, basic information, including definition, ... analysis, and news analysis, etc. , For ... Palmitic Acid market in China and ...
(Date:11/26/2014)... , Nov. 25, 2014 Bio-Techne Corporation (NASDAQ: ... appointed Robert Gavin to serve in a ... Protein Platforms Division.  Mr. Gavin will be responsible for ... which includes the ProteinSimple business acquired in July 2014 ... San Jose, California -based ProteinSimple develops and ...
Breaking Biology Technology:2019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 22019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 32019 Biostimulants Market to Grow at a CAGR of 12.5% Says a New Research Report Available at RnRMarketResearch.com 4SoundConnect Appoints Director of Channel Development & Sales 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3
... , NORTH BILLERICA, Mass., Sept. 9 ... development of instruments for assessing cellular bioenergetics, today announced it ... power of the XF Extracellular Flux Analyzer in revealing the ... glycolysis in cancer cells. The data will appear in ...
... CLEVELAND, Ohio and DENVER, Colorado, September 9 ... training,products for clinical professionals, today announced the appointment of ... eLearning and Content,business. , Mr. ... building innovative information products and services for a variety ...
... JERUSALEM, September 9 Oramed Pharmaceticals,Inc. (OTCBB: ORMP.OB), a ... has received approval from the Institutional Review Board (IRB),to ... This approval was,granted after successful pre-clinical results were reported. ... University Medical Center in,Jerusalem. , ...
Cached Biology Technology:Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference 2Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business 2Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog 2Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog 3
(Date:11/21/2014)... Strict laws against distracted driving and the ... American and European automotive sector towards gesture recognition technologies. ... that are intuitive and able to retrieve information with ... New analysis from Frost & Sullivan,s Strategic ... Europe and North America ...
(Date:11/18/2014)... WASHINGTON , Nov. 18, 2014  The ... Security Industry Association today jointly announce the formation ... and release of its Identity and Biometric ... (Framework). The Framework received official support from BORDERPOL, ... governments to improve and provide expertise regarding border ...
(Date:11/18/2014)... , Nov. 18, 2014   EyeLock ... authentication solutions, and MorphoTrust USA (Safran), ... services, today announced a strategic partnership to offer ... motor vehicle administration (MVA), airport screening and financial ... identity-related solutions, MorphoTrust serves consumers through a nationwide ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... created a continuous chemical process that produces useful crude oil ... verdant green paste with the consistency of pea soup. ... Northwest National Laboratory was reported recently in the journal ... licensed the technology and is working with an industrial partner ...
... that people who drink moderate amounts of alcohol actually have ... and have better cardiovascular function that those who don,t drink ... & Science University adds a fascinating twist: moderate drinking may ... infection. The research, published Dec. 17 in the journal ...
... upward of 170,000 people worldwide this year, but bladder cancer ... fatal the disease must metastasize to faraway sites. The question ... eventually become the more dangerous, muscle-invasive (MI) form of the ... from the start? A University of Colorado Cancer ...
Cached Biology News:Algae to crude oil: Million-year natural process takes minutes in the lab 2Algae to crude oil: Million-year natural process takes minutes in the lab 3Study: Moderate alcohol consumption boosts body's immune system 2Study: Moderate alcohol consumption boosts body's immune system 3Muscle-invasive and non-muscle invasive bladder cancers arise from different stem cells 2
...
...
Rabbit polyclonal to Staphylococcus Enterotoxin E (Biotin) ( Abpromise for all tested applications)....
Rabbit polyclonal to Peptide E ( Abpromise for all tested applications)....
Biology Products: